Telix Pharma



Telix is a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR).

Gabriel Liberatore
Group Chief Operating Officer
Douglas Cubbin
Group Chief Financial Officer
Jonathan Barlow
Chief Business Development Officer and General Counsel
David N. Cade
President, Telix Asia Pacific (APAC)
Shintaro Nishimura
President, Telix Japan
Richard Valeix
President, Europe, Middle East and Africa (EMEA)
Bernard Lambert
President, Americas
Tracey Brown
SVP Global Clinical Operations
Colin Hayward
Group Chief Medical Officer
Michael Wheatcroft
Chief Scientist
Melanie Farris
Chief Governance and Risk Officer & Group Company Secretary
Caroline Defraiteur
General Manager, Herstal, Europe
Andreas Kluge
Chief Medical Advisor

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.